|generic vs. original med
Apr 26, 2013
My health Ins just asked me to switch from Viread to generic of it and Lamivudine...I just read in 4/2013 issue of "Tagline" from T A G-Treatment Action Group in NY that says it might not be a good idea (Pg 11) What are your feelings? Thank you. Bill Webber
| Response from Dr. Young
Hi Bill and thanks for posting.
The TAGline article that you've cited is a nice summary of the questions and issues related to the emergence of generic medications.
There's quite a lot of controversy (mired no doubt by a lot of commercial issues too) about how important the differences between FTC (emtricitabine, part of Atripla, Complera and Stribild) and 3TC (lamivudine, Epivir and part of Epzicom) are. The former is on-patent and the later is now available as a generic medication in the US.
I feel pretty strongly that the differences are likely to be trivial when the medication is added to strong partners (as noted in the article). Further, changing a suppressive regimen to a newer (or even if true, less potent one) probably places fewer demands on potency than when starting with a detectable viral load. Taken together, if you've been doing well on Truvada (suppressed virus and no toxicity), switching to Viread and generic lamivudine should be ok.
Please let us know how the transition works for you. I'm sure that many of our readers would be interested.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.